SCHEMBL3620490

SCHEMBL3620490

COc1cccc(C(Cl)=C(Cl)Cl)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.60
CES1 P23141 1/20 0.60
NPC1 O15118 4/20 0.56
RAB9A P51151 4/20 0.56
PARP1 P09874 1/20 0.56
PRSS1 P07477 1/20 0.56
PRSS2 P07478 1/20 0.56
PRSS3 P35030 1/20 0.56
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
ABCG2 Q9UNQ0 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PDE4A P27815 1/20 0.47
PDE4B Q07343 1/20 0.47
PDE4C Q08493 1/20 0.47
PDE4D Q08499 1/20 0.47
ESR1 P03372 1/20 0.47
ESR2 Q92731 1/20 0.47
ACHE P22303 1/20 0.47
CHRM2 P08172 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28535468 0.82 CES2 (0.58) CES2CES1NPC1RAB9APARP1
SCHEMBL24402 0.80 CES2 (0.71) CES2CES1NPC1RAB9APARP1
SCHEMBL29626810 0.80 CES2 (0.71) CES2CES1NPC1RAB9APARP1
SCHEMBL3624666 0.79 ALDH1A1 (0.46) CES2CES1NPC1RAB9APARP1
Ethane SCHEMBL27287143 0.78 CES2 (0.69) CES2CES1NPC1RAB9APARP1
SCHEMBL9688906 0.78 CES2 (0.53) CES2CES1NPC1RAB9APARP1
SCHEMBL2121043 0.77 NPC1 (0.58) CES2CES1NPC1RAB9APARP1
SCHEMBL2121044 0.77 NPC1 (0.58) CES2CES1NPC1RAB9APARP1
SCHEMBL8252989 0.77 NPC1 (0.58) CES2CES1NPC1RAB9APARP1
SCHEMBL4958740 0.77 NPC1 (0.68) CES2CES1NPC1RAB9APARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7834062-B2 Aminoalkylphenols, methods of using and making the same MERCK SHARP & DOHME CORP. (US) 2010-11-16 US disclosed
US-20090298949-A1 AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME MERCK SHARP & DOHME LLC 2009-12-03 US disclosed
US-7589127-B2 Aminoalkylphenols, methods of using and making the same MERCK & CO., INC. (US) 2009-09-15 US disclosed
EP-1517879-A4 AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME MERCK & CO INC (US) 2006-09-13 EP disclosed
US-20050234265-A1 Aminoalkylphenols, methods of using and making the same MERCK SHARP & DOHME LLC 2005-10-20 US disclosed
EP-1517879-A1 AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME Merck & Co., Inc. (US) 2005-03-30 EP disclosed
WO-2004000783-A1 AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME MERCK & CO., INC. (US) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298949-A1 AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME NPEPPS, PHOSPHO1, LNPEP CES2 331/4885CES1 3527/4885NPC1 3015/4885
US-20050234265-A1 Aminoalkylphenols, methods of using and making the same NPEPPS, PHOSPHO1, LNPEP CES2 331/4885CES1 3527/4885NPC1 3015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.